Extended Data Table 4.
Aβ− controls | Aβ+ AD | |
---|---|---|
Sample size | 14 | 16 |
Age, y | 68.43 ± 9.835 | 76.63 ± 5.512* |
Sex, F, n (%) | 5/14 (35.7%) | 9/16 (56.3%) |
CSF Aβ42, pg/ml | 1110 (672.8–1168) | 457 (420.3–515)* |
CSF total-tau, pg/ml | 297 (175.8–354) | 635 (496.5–999.3)* |
CSF p-tau181 (Innotest), pg/ml | 48 (32.5–57.3) | 84 (71.8–100.5)* |
Plasma p-tau212, pg/ml | 1.0 (0.5 – 1.7 | 3.8 (2.6–6.8)* |
Plasma p-tau231, pg/ml | 4.9 (4.4 – 6.6) | 11.22 (9.1–16.1)* |
Plasma p-tau181, pg/ml | 4.488 (3.7 – 6.7) | 8.377 (7.2–12.4)* |